Abiopharma

New Form 144 - UroGen Pharma Ltd. Filed: 2025-09-09 AccNo: 0001976408-25-000295 Size: 4 KB

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health

Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules

Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer

Modeyso™ (dordaviprone) Included in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma

Owlet Baby Care Inc. - Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor

Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor

Agenus Inc. - France Grants Reimbursed Compassionate Access (AAC) forAgenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

New Form 8-K - Xilio Therapeutics, Inc. Filed: 2025-09-09 AccNo: 0001558370-25-011949 Size: 195 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - GSK plc Filed: 2025-09-09 AccNo: 0001654954-25-010505 Size: 8 MB

Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Achievement of $17.5 Million Development Milestone Under Exclusive License Agreement with Gilead

Aveanna to Participate at the Jefferies Healthcare Services Conference

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness